Triple therapy in Rheumatoid Ahritis involves all except: (A) Methotrexate, (B) Hydroxychloroquine, (C) Steroids, (D) Sulphasalazine
Answer is C. Methotrexate is the DMARD of the first choice for initial treatment of moderate to severe RA. Failure to achieve adequate improvement with methotrexate therapy calls for a change in DMARD therapy, usually transition to an effective combination regimen. Effective combinations include methotrexate, sulfasalazine, and hydroxychloroquine (oral triple therapy); methotrexate and leflunomide; and methotrexate plus a biological.Reference: Harrison&;s Principles of Internal Medicine; 19th edition; Chapter 380; Rheumatoid ahritis